or Try an Advanced Search...

    Technical Analysis for KNSA - Kiniksa Pharmaceuticals, Ltd.

    Grade Last Price % Change Price Change
    C 19.01 2.37% 0.44
    KNSA closed up 2.37 percent on Friday, May 31, 2024, on 1.9 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Down
    Historical KNSA trend table...
    Date Alert Name Type % Chg
    MACD Bearish Centerline Cross Bearish 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Outside Day Range Expansion 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish 2.37%
    BB Squeeze Ended Range Expansion 2.37%
    Older End-of-Day Signals for KNSA ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance 1 day ago
    Rose Above Previous Day's High 2 days ago
    Rose Above 50 DMA 2 days ago
    Outside Day 2 days ago
    Fell Below Lower Bollinger Band 2 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    KNSA Chart by TradingView
    Basic chart:

    Profile

    Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Disease Medication Pharmacology

    Is KNSA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
    Apr 24 Kiniksa Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Apr 24 Kiniksa Pharmaceuticals: Arcalyst Performs While Abiprubart Plans Take Shape
    Apr 24 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript
    Apr 23 Kiniksa Pharmaceuticals, Ltd. (KNSA) Q1 2024 Earnings Call Transcript
    Apr 23 Kiniksa Pharmaceuticals, Ltd. 2024 Q1 - Results - Earnings Call Presentation
    Apr 23 Kiniksa Pharmaceuticals Ltd (KNSA) Q1 2024 Earnings Overview: Surpasses Revenue Forecasts
    Apr 23 Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates
    Apr 23 Kiniksa Pharmaceuticals reports mixed Q1 results; raises FY24 outlook
    Apr 23 Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
    See more KNSA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.09
    52 Week Low 13.56
    Average Volume 351,138
    200-Day Moving Average 18.00
    50-Day Moving Average 18.82
    20-Day Moving Average 19.56
    10-Day Moving Average 19.16
    Average True Range 0.55
    RSI (14) 47.92
    ADX 19.17
    +DI 18.97
    -DI 22.18
    Chandelier Exit (Long, 3 ATRs) 18.88
    Chandelier Exit (Short, 3 ATRs) 19.97
    Upper Bollinger Bands 20.61
    Lower Bollinger Band 18.52
    Percent B (%b) 0.24
    BandWidth 10.69
    MACD Line -0.01
    MACD Signal Line 0.13
    MACD Histogram -0.1427
    Fundamentals Value
    Market Cap 673.14 Million
    Num Shares 35.4 Million
    EPS -0.11
    Price-to-Earnings (P/E) Ratio -172.82
    Price-to-Sales 5.38
    Price-to-Book 3.52
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 20.13
    Resistance 3 (R3) 20.02 19.55 19.94
    Resistance 2 (R2) 19.55 19.26 19.60 19.88
    Resistance 1 (R1) 19.28 19.09 19.41 19.38 19.82
    Pivot Point 18.80 18.80 18.87 18.85 18.80
    Support 1 (S1) 18.53 18.52 18.67 18.64 18.20
    Support 2 (S2) 18.06 18.34 18.11 18.14
    Support 3 (S3) 17.79 18.06 18.08
    Support 4 (S4) 17.89